Psychedelic Stocks,Shroom News MYND Life Sciences Secures Canadian Securities Exchange Listing By Dennis Mutua May 27, 2021 Leading psychedelic development company focused on improving mental health MYND Life Sciences Inc. announced having received an approval to get listed on the Canadian Securities Exchange (CSE). Shares of the company will commen...
Psychedelic Stocks,Shroom News Silo Pharma Files For Nasdaq Up-listing By Dennis Mutua May 26, 2021 Development stage biopharmaceutical company specializing in merging traditional therapeutics with psychedelics research Silo Pharma Inc. (OTCMKTS: SILO) announced having submitted an application for Nasdaq up-listing on May 25. ...
Psychedelic Stocks,Shroom News MindMed Enters Into an MOU With Nextage to Devolop Brain Psychedelic Drug Targeting Liposome Sysytem By Dennis Mutua May 25, 2021 Psychedelic medicine biotechnology company focusing on discovering, deploying and deploying psychedelic infused medicines MindMed Inc. (MNMD) has entered in a Memorandum of Understanding (MOU) with Israel based Nextage Therapeutic...
Psychedelic Stocks,Shroom News Dr. Mark Wingertzahn Appointed Chief Scientific Officer in Wesana Health By Dennis Mutua May 24, 2021 Emerging life sciences company focusing on deployment and delivery of psychedelics and naturally extracted therapies to treat traumatic brain injuries Wesana Health Holdings Inc. (CSE: WESA) announced having appointed Dr. Mark Win...
Featured,Shroom News MindMed Secures Approval of Mescaline Study By Dennis Mutua May 21, 2021 Leading psychedelics company developing and deploying psychedelics-inspired medicines to improve mental wellness MindMed Inc. (MNMD) (NEO: MMED) announced having been granted approval to commence its phase 1 clinical trial evaluat...
Psychedelic Stocks,Shroom News Lobe Sciences Enters Into a Production and Supply Agreement With HAVN Life Sciences By Dennis Mutua May 20, 2021 Life sciences company focusing on research and development of psychedelics medicines Lobe Life Sciences (CSE: LOBE) (OTCMKTS: GTSIF) announced having entered into a production and supply agreement with biotechnology company specia...
Psychedelic Stocks,Shroom News Cybin Cleared to Commence Clinical Trial on Psilocybin Oral Film By Dennis Mutua May 19, 2021 Biotechnology company specializing in advancing psychedelics therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems and treatment for mental disorders Cybin Inc. (OTCMKTS: CLXPF) announc...
Psychedelic Stocks,Shroom News Revival Therapeutics Inks Deal With LTS Lohmann to Develop Oral Psilocybin Thin Film Strip By Dennis Mutua May 18, 2021 Life Sciences company focusing on research and development of treatments for medical needs and rare disorders Revival Therapeutics Ltd. (CSE: RVV) announced have signed an agreement deal with LTS Lohmann Therapie-Systeme AG to joi...